Christophe Bernard.

Christophe Bernard

Director of research
Institute of Systems Neuroscience

Christophe Bernard is director of research at the Institute of Systems Neuroscience, INSERM U1106. His main interest is to understand brain dynamics in health and disease, with a focus on epilepsy.

He acts as a reviewing editor for Science Advances, and formerly for Science and the Journal of Neuroscience. He created and is the editor-in-chief of eNeuro, the online open-access journal of the Society for Neuroscience. eNeuro is designed to serve and educate the neuroscience community, promoting reproducibility, publishing negative results and sensitizing scientists to open science and better data interpretation with a focus on statistics and experimental bias.

Bernard obtained his Ph.D. in neuroscience from Pierre and Marie Curie University, did his postdoctoral research at the University of Southampton and spent a sabbatical at Baylor College of Medicine. He participated in the development of organic technologies to record and control brain activity, which earned him the Felix Innovation Prize, and in the development of the Virtual Mouse Brain.

Explore more from The Transmitter

Human X and Y chromosomes.

Extra Y chromosomes are linked to autism

Data from people with more or fewer than two sex chromosomes could help answer questions around genetic protection and vulnerability.

By Grace Huckins
5 December 2024 | 5 min read
By clicking to watch this video, you agree to our privacy policy.

Grace Hwang and Joe Monaco discuss the future of NeuroAI

Hwang and Monaco organized a recent workshop to hear from leaders in the field about how best to integrate NeuroAI research into the BRAIN Initiative.

By Paul Middlebrooks
4 December 2024 | 97 min listen
Illustration of an open journal featuring lines of text and small illustrations of eyes and mouths.

Anti-seizure medications in pregnancy; TBR1 gene; microglia

Here is a roundup of autism-related news and research spotted around the web for the week of 2 December.

By Jill Adams
3 December 2024 | 1 min read